Latest / The Eye Believe Podcast / What’s Up, Doc? Featuring Dr. Omid Hamid | The Eye Believe Podcast

Transcript

What’s Up, Doc? Featuring Dr. Omid Hamid | The Eye Believe Podcast · The Eye Believe Podcast

0:03
hey everyone
0:03
welcome back to the Eye Believe Podcast
0:05
this is another episode of our series
0:07
What's Up, Doc?
0:08
Today we are joined with Dr. Omid Hamid
0:11
welcome Doctor Hamid
0:13
thank you so much for having me
0:14
it's a pleasure to be here absolutely
0:17
so we're gonna just jump in
0:19
and I would love it
0:20
if you would just
0:20
tell us a little bit about your backstory
0:22
where you grew up
0:24
sure yeah
0:25
I'm a my backstory is I'm an immigrant from Iran
0:31
I came here like
0:33
into the States at 6 years old
0:36
went to New York for a little bit
0:38
and was in Florida for a short amount of time
0:41
and then at that high school age
0:44
I came to Los Angeles and I've been here since
0:48
awesome how do you like Los Angeles
0:51
Los Angeles is a you know
0:53
entity onto itself very lovely
0:56
beautiful weather interesting people
0:59
academically it's uh
1:02
much maligned but wonderful
1:04
there's an opportunity to collaborate
1:08
and while having a somewhat normal lifestyle
1:12
that's fantastic so
1:14
when did you first know that you wanted to be a doctor
1:19
yeah that's a difficult question that you ask people
1:22
I think most patients who come into the medical field
1:26
or most persons who come to the medical field uh
1:30
they have some inkling that they wanna help
1:33
that they wanna contribute
1:35
so early on they've done work that's contributing
1:41
they may not realize they want to be in medicine
1:44
for me I have had a parent
1:46
who was very much interested in having a uh
1:50
child as a physician he was enamored with the field
1:56
my father worked in medical manufacturing
1:59
so we spoke about it a lot
2:00
I grew up around phenomenal physicians
2:05
not as my physicians but in
2:07
in the community
2:09
and I enjoyed the dedication and the respect of the job
2:15
and as I grew up and was interested in science
2:20
I realized that
2:22
that's a major confluence in the medical field now
2:25
basic science along with um
2:29
patient care proximity to people uh
2:33
real value in in work output and
2:39
and now the the science is exploding
2:43
so it all helped to keep me interested
2:47
and ramp ramped up as I was doing my training
2:53
how did you first get involved with ocular melanoma
2:57
so it's very interesting that I really wasn't involved
3:01
and didn't understand my role in melanoma care until
3:07
towards the end of my fellowship
3:09
and during fellowship I
3:11
I was fortunate enough to work with Jeff Weber who
3:15
as you know is a great
3:17
in the field as far as educating
3:20
mentoring clinical trials etcetera
3:23
but I was not slated to go into cutaneous malignancies
3:28
actually the opposite
3:30
uh more uh
3:32
genito urinary but as the field expanded
3:36
I had an opportunity to shift gears
3:40
and get into immunotherapy
3:42
and melanoma was the place
3:45
uh
3:48
and ocular melanoma came along with it
3:51
those of us who've been around long enough
3:53
to know that there wasn't a lot to do uh
3:57
remember how we tried to find these niche
4:02
uh these niche therapies for ocular melanoma
4:05
and that usually happened
4:08
where all ocular melanomas were somewhat
4:10
referred to people who subcutaneous melanoma
4:14
so that's how I got into it
4:17
and what type of doctor are you
4:21
I think I'm a hybrid physician um
4:26
I'm an academic community
4:30
uh investigator
4:31
I would say
4:31
so that means that I have a practice that's rooted into
4:36
in the community
4:38
uh The Angeles Clinic and Research Institute
4:41
it is freestanding um
4:44
in the midst of Los Angeles
4:47
it's also academic in our clinical trials
4:51
and in our contributions and academic
4:54
in its affiliation with Cedar Sinai Medical Network
4:59
as we try to increase Cedar Sinai University
5:05
so I would say if you ask me
5:07
I would say well
5:09
I'm a community DOC
5:10
that's how I'm introduced by some academics
5:13
cause I have a huge practice
5:15
I see patients 4 to 4+ days um
5:19
when I go to community centers
5:21
they introduce me as an academic physician
5:23
because I have a I had a huge research uh
5:28
program that's involved in phase 1 uh
5:32
immunotherapies targeted therapies uh
5:35
novel therapeutics
5:36
and we've been fortunate enough to be part of uh
5:40
for ocular melanoma some of the novel targeted agents
5:44
uh the Imtax through immunocore and of course
5:48
the checkpoint inhibitors
5:50
and then uh I think the third thing is uh
5:54
mentorship and
5:56
and I take great pride in working to mentor
6:00
some of the younger doctors
6:01
that have come through here
6:02
and gone on to better um
6:06
academic settings or uh larger community roles
6:13
that's amazing so
6:14
I'd like to give you an opportunity
6:16
to brag on The Angeles clinic for a minute
6:18
and tell us all the great things
6:20
that you guys are doing there as a clinic
6:23
right I think that The Angeles clinic is actually
6:30
an amazing place uh
6:32
where patients and physicians and support come together
6:39
uh we're freestanding
6:41
uh we're located in West LA
6:43
we have a robust clinical trials system
6:49
and we are able to do that
6:51
because everything is here to assist in
6:56
I guess the agility to take care of patients
7:00
there's a clinical trials program
7:02
there's imaging that means CT scanners MRIs
7:06
along with the imaging
7:07
comes the real strength of our program
7:09
our radiologists or interventionalists also
7:13
so biopsies injections into viscera uh
7:17
the ability to do uh core to obtain uh
7:23
treatments even TIL is here
7:26
um we have labs
7:28
supportive care whether it's genetics
7:30
social work nutrition
7:33
um we have our own CRO
7:35
which helps us open trials in an expedited fashion
7:39
and then we have our physicians who each have an
7:42
a field of interest
7:44
and are great advocates for our patients
7:47
and that's all brought together
7:49
by our clinical trials team
7:51
and that's the main heartbeat of what we do here
7:55
we love to have uh what people call bench to bedside
8:01
which means do the we have lab people that we work with
8:05
we bring in trials at the earliest time
8:09
Shepherd them through and take them to approvals
8:13
or take them to major randomized phase 3 trials
8:17
so bench to bedside or farm to table wherever
8:21
however you think about it
8:24
that's fantastic and you get to be in Los Angeles
8:26
so I feel like that's a win win
8:29
it's alright there every
8:31
every place is great
8:33
and I think when you walk into a center like ours
8:39
Sloan MD Anderson Moffitt
8:43
all these places I think when you walk through
8:47
it doesn't matter where you are
8:48
I don't think you sense that you're in LA
8:50
we all have the same goals
8:52
and you know spend enough time here
8:57
that sort of forget that there is an outside world
9:00
definitely
9:02
so my next question is a little bit of a hard one
9:04
what do you believe makes a great doctor
9:08
I think you get a billion different answers for that
9:13
for a great doctor to some
9:16
is someone who's caring just caring
9:19
great doctor to some
9:21
is someone who's smart you know
9:24
well he knows all of this stuff
9:26
and he understands all this stuff
9:28
uh at times
9:29
a great doctor is someone who's available
9:32
you know we're open six to seven
9:38
you know 6:00am
9:39
seven PM here so we're available
9:41
we can see patients within 24 hours
9:44
whereas in certain places
9:45
it takes weeks or there is no availability
9:49
uh personally
9:52
a great doctor
9:54
part of it and I think this is possibly novel
10:01
a way to look at it
10:02
is someone who thinks that it's not just uh
10:06
work life balance it's life
10:08
work balance that
10:09
the understanding that the work that we do
10:13
needs to have value
10:14
in order for the life that we lead to have meaning
10:18
so that's always been my idea of a great doctor
10:24
someone who shares that view
10:26
and it
10:27
whether it's a plastic surgeon or an infertilitist
10:31
or an internist or a surgical oncologist
10:36
just valuing the identity of being a physician
10:42
and all that it requires
10:46
absolutely and if someone comes to you
10:49
and they're gonna be your patient
10:50
what can they expect from you
11:23
well I'm not gonna put it on paper but
11:28
I I think I've had the good fortune
11:31
of being exposed to some of the greatest physicians
11:36
in our field
11:38
and so they'll expect me to work to meet that ideal
11:44
and part of that is advocacy
11:48
advocating for them or their cadre
11:51
part of that is availability
11:55
another part of it is communication and collaboration
11:58
so all of those things
12:00
yeah all very important things
12:02
and what is your overall approach
12:05
to treating ocular melanoma
12:09
um
12:09
the overall approach is that ocular melanoma requires
12:14
um a multidisciplinary team
12:18
that is available to the patient
12:21
that doesn't mean a team that is all in one university
12:25
it's a team that's in multiple different places
12:27
for example
12:29
whether it's um
12:33
our interventionalists or a
12:36
an interventional physician at another institution
12:39
or my surgical oncologist
12:42
they all have to be available
12:44
the pathologist um
12:47
at at certain times to evaluate what we're doing um
12:52
the medical oncologist
12:53
but also the social work and the supportive care
12:56
um all of those things
12:59
and additionally
13:02
a robust clinical trials program
13:06
and the other thing that I would say is
13:09
I just wrote an email to uh
13:12
Doctor Orloff at Jefferson
13:14
uh it requires the ability to have the humility
13:20
to ask others who know better
13:23
hey listen
13:24
we're I I have this person
13:27
what can we do
13:29
uh can we get you there
13:31
can we get them there I mean
13:32
I think in uveal melanoma TIL has become a very uh
13:39
interesting therapy but access
13:41
has been you know
13:43
extremely difficult it's the biggest obstacle
13:48
so we make phone calls uh
13:51
to our colleagues
13:52
whether they be at Sarah Cannon or UPMC etcetera
13:59
uh so it
13:59
it just takes the idea that there should be many lines
14:07
feeding into the care of one patient
14:11
absolutely
14:12
so when there are multiple treatment options
14:15
how do you guide patients
14:16
through that decision making process
14:18
and what role do you believe the patient plays
14:21
in the decision making
14:23
oh yeah
14:24
this is a great question for ocular melanoma because uh
14:30
initially the physician puts out
14:31
all of the options that are available
14:34
and then
14:35
the physician should talk about the most optimal
14:38
therapeutic pathway forward
14:42
uh and then step back
14:44
and allow the patient to decide
14:46
whether that optimal pathway
14:49
really does feed into the life
14:51
and the lifestyle that the patient has
14:54
and the and then the
14:56
the toxicities that the patient is willing to endure
15:00
I think for us it's always a discussion
15:02
and then we turn around and come back uh
15:06
and say listen
15:08
we can get started on this and then wait to hear more
15:13
you know we can give you some time to make a decision
15:16
and then come back and while you do that
15:19
I think the always the most interesting part is to say
15:23
how about
15:23
we also create the ability to have a second opinion
15:29
consultation
15:31
so I have an ocular melanoma patient
15:33
that most people who be listening here
15:35
will understand or or know who he she is
15:42
uh but this person
15:45
uh
15:46
consistently seeks the counsel of multiple
15:52
uh oncologists
15:54
interventionalist radiologist
15:57
um and he is savvy enough to understand the data and
16:04
and will schedule an appointment to discuss the data
16:07
and how it will affect him in the future
16:09
not just now
16:11
and that's not everyone can do that
16:14
but what I've learned in taking care of this person is
16:19
you know he goes out and does all of these
16:21
because that's his mantra
16:25
and as physicians we do that all the time
16:28
or we need to be doing that all the time
16:32
that's what a meeting like ASCO is
16:34
that's what the Melanoma Research Alliance meeting is
16:37
that's what uh
16:38
COOG is um
16:40
or Cure Om or AIM at melanoma
16:45
all of these resources need to be brought together
16:48
in order to help us meet and talk about what's going on
16:53
and
16:53
or to be able to send a patient there for assistance
16:58
those things that's how we take care of the patients
17:02
love that answer so I
17:04
I know that you touched on multidisciplinary teams
17:07
already but my next question was going to be
17:09
how do you work with other specialists
17:11
to provide the best care and
17:12
what should patients know
17:14
about being part of a multidisciplinary team
17:17
a multidisciplinary team
17:18
do you wanna touch on that again
17:19
or do you feel like you've covered that
17:21
I think we've touched on it
17:22
but I think you know
17:23
the realist in me wants to just take a step back
17:26
and say that that's a lot of time and a lot of effort
17:30
and so uh
17:32
it can be done at specific
17:36
you know forks in the road for therapy
17:39
the the issue becomes
17:41
when
17:41
that expectation is that it's being done all the time
17:45
and it's not that's not necessary um
17:48
when you have good lines of communication and in
17:52
in understandings
17:55
okay yeah absolutely
17:57
so next question is
17:59
what advancements are most exciting to you right now
18:04
um
18:06
well I
18:07
as far as advancements
18:09
I think this understanding that we now have
18:13
about targeting the tumor
18:17
so the idea data that's come is
18:21
is interesting
18:22
we're gonna really have to understand where it belongs
18:24
in the setting for HLA-2 positive patients versus
18:28
HLA-2 negative patients
18:31
the ability to do TIL not as a standard
18:34
but to understand its role and to get more data
18:38
is important and we're actively
18:41
actively asking some of these companies to
18:45
you know dip their toe and fall in
18:50
whether it's Tebentafusp or Brenetafusp
18:56
there there
18:59
yeah
19:00
interesting on their own
19:01
and as we move forward to the uh
19:05
TCR-T
19:07
uh therapies like the Immatics trial
19:11
what is mind blowing now
19:13
is that there are multiple randomized trials ongoing
19:17
that may lend itself to approvals or access
19:21
whether it's the RP2 drug from Replimune
19:24
or the Immatics drug
19:26
or some of the novel stuff that's coming from
19:32
Immunocore and their ImmTAX platform
19:36
or the antibody drug conjugates
19:39
that looked very promising
19:41
but is now in a holding pattern at um
19:45
at Novartis
19:47
those things will help us understand the metastatic uh
19:52
paradigm
19:54
and we'll have more than just one or two tools
19:57
I will say that
20:01
where we are going to have a lot of options
20:05
and that I never thought would be possible
20:08
and that we'll have to sift through this data
20:11
but it represents a huge win for our patients
20:15
is not just the metastatic therapies
20:18
not just the local therapies like Hepzato
20:21
but now multiple trials
20:24
looking for high risk patients in the adjuvant setting
20:28
are coming forth
20:30
so that's it that I think is amazing
20:36
uh that
20:37
I think is the place uh
20:38
that we'll be getting a lot of information
20:43
I am
20:45
unsure of how we are going to get those patients in
20:49
I know that it's gonna depend on a lot of people
20:52
like yourself
20:54
A Cure In Sight
20:55
needs to inform patients that these trials are there
21:00
and that the physicians on our side
21:03
need to be informing our colleagues
21:05
listen you got to send these patients
21:08
for these adjuvant options
21:10
or these appropriate metastatic options
21:13
we have to be involved and
21:16
and that's where the field is running to
21:19
we need to come together advocacy
21:23
uh patient care pharma
21:27
and expand the options
21:30
and then tease out the benefits for each subgroup of
21:33
of patients
21:36
absolutely and A Cure In Sight
21:37
does actually have a clinical trial list
21:40
on our website it's updated
21:42
I think once a year
21:43
so it might not always be exactly up to date
21:45
but Kevin works really hard to go to ASCO
21:48
and all the conferences
21:49
and keep it as up to date as he can
21:51
so definitely check out ACureInSight.org
21:53
for those clinical trials
21:55
it's great and let me step back and say the following
21:59
that anyone listening to something like this
22:01
or reading the transcripts or picking out a snippet
22:05
when they're diagnosed with ocular melanoma
22:07
needs to go to these places
22:10
whether it's A Cure In Sight
22:11
or other and if they don't see what's there
22:15
they need to contact and ask for referral
22:20
we work together very closely
22:21
I see Kevin all the time
22:24
and list is great but
22:27
the place where it really works
22:29
is when a patient needs to be seen
22:32
or needs some expertise
22:34
and you pick up the phone on your end
22:36
and make the introductions
22:37
and so that's a that's a huge resource
22:40
that's not on the web or it's not in a pamphlet
22:44
the ability to advocate for patients
22:47
through your establishment
22:49
is amazing you should be commended for it every day
22:54
well thank you so much
23:13
so I'm just gonna ask you a few questions
23:15
that are a little more personal now
23:17
um what keeps you going on the hard days
23:21
I don't know the failure
23:23
I think people want me to say like
23:25
the failure keeps me going
23:27
oh my goodness but I'm fortunate enough
23:30
the success is like it's like a drug
23:33
it's so happy and granted
23:36
we're not at the place
23:37
where we have had great successes recently
23:40
but we all want that same validation
23:44
of the work that we do
23:46
what keeps me going
23:47
is that it is the value of contributing
23:52
of knowing that the
23:54
that the work is moving the field forward and and and
23:59
and that's sort of misconstrued as saying like
24:02
that the trials are the most important thing
24:04
it's not true the patients are the most important thing
24:08
um but look at where we are now
24:13
there is the ability
24:14
to have someone be part of a clinical trial
24:18
maybe or maybe not getting the drug of record
24:21
but being on the trial benefiting
24:25
and by the time that they are off the trial
24:29
or the trial is closed within a
24:33
a year or so that drug being approved
24:37
and ready to be utilized in their care again
24:40
see how that feeds right back
24:42
or being able to be utilized
24:45
in the care of another patient
24:46
who will then you either be on that drug
24:49
or that drug in a clinical trial
24:51
or something else after that
24:53
and we'd then end up just feeding back into this loop
24:58
that is a loop that lends us to success
25:04
and that really didn't happen twenty years ago
25:07
when I just finished fellowship
25:08
you got onto a trial
25:10
it was years before that data came out
25:13
it was a difficulty to really understand it
25:17
and now we are working at such a hyperspeed
25:21
I had patients who were on the phase 1 Keytruda trials
25:26
who by the time they were off
25:30
or they needed something Keytruda was already available
25:35
and in combination trials uh
25:38
same with the Opdivo (nivolumab)
25:41
and that wasn't what we had with Yervoy
25:44
and so you so you see here where we are
25:47
we are in a place where we can improve outcome
25:51
significantly in a short amount of time
25:54
now we have to be able to give that to 100% of patients
25:59
and that's what keeps me going
26:02
what do you love doing outside of work
26:09
I don't know love is a strong word
26:13
enjoy
26:14
my new thing is trying to find uh
26:18
some sort of Zen relaxation through golf
26:22
I'm trying to learn how to do that I'm not good at it
26:27
as I hear most people aren't great at it
26:31
I came to it trying to find some comfort
26:36
but find that it's it's a nice outdoorsy activity
26:40
but you're met with the same obstacles of improvement
26:44
of understanding etcetera
26:46
so I like to do that and
26:52
I love spending time with my family
26:54
I have two young kids um
26:57
and it's been a joy to see them grow
27:00
and have inquisitive minds
27:02
that keeps me going that uh
27:06
by seeing their uh
27:08
growth and their questions
27:10
it lends itself to being comfortable in my shortcomings
27:16
and uh
27:18
my desire to ask and get some questions answered
27:23
fantastic alright
27:25
we're gonna go into our lightning round
27:27
where I'm just gonna throw some questions at you
27:28
and you just give me some quick answers
27:30
so the first one is
27:31
what is your go to coffee order or tea
27:35
my go to coffee order is black
27:38
black alright
27:39
morning person or night owl
27:41
oh go ahead
27:42
uh I'm both
27:43
I get up very early and I tried to resist the the night
27:51
if there's a way that I could give up my sleep
27:54
to someone else there please come by and pick it up
27:57
because
28:01
you get more done between 5:00am and 8:00am
28:04
than you do between you know
28:06
5:00pm and 10:00pm
28:09
but the evening is a great time to review to read
28:15
to just you know
28:17
calm down and get yourself ready for the next day
28:23
what's your favorite way to spend a day off
28:28
yeah
28:30
you know most uh
28:32
physicians who are like me will
28:35
will not give this answer
28:37
but it's in their mind uh
28:39
my favorite way to spend a day off is to get
28:42
get the errands I wanted done uh laundry
28:47
haircut uh
28:49
gym
28:51
you know get into the pool and maybe do some swimming
28:55
which I don't do as much as I want to go
28:57
go see people go to places that are not open
29:01
when I want them to be open
29:04
and so that's how I'd like to spend a day off
29:07
most physicians work a lot
29:09
and they dedicate some part of their weekend to it
29:13
um
29:15
for me I've I
29:17
I think a day off will help me to rearrange things um
29:24
uh
29:25
what does that mean uh
29:27
LACMA's opened here there's a new Geffen here
29:30
and I need to figure out a way to arrange to be there
29:33
so uh
29:35
those are the things
29:37
uh golfing
29:38
as I said um
29:40
at some point we need to um
29:45
think about a retirement or working less
29:48
and I would hate to find myself at retirement
29:53
without something to do during retirement
29:57
so for sure yeah
29:59
okay what is your favorite vacation spot
30:04
oh I love Italy
30:07
yeah I do
30:09
that's my favorite vacation spot
30:12
um
30:13
I'm fortunate enough to have a partner
30:16
who loves to travel who uh
30:20
sets up the Hamid family um
30:23
summer and winter plans but usually we try to get there
30:26
and there's so much of that place
30:28
that you haven't seen yet
30:31
so that's great
30:32
we went to the Sicily last time
30:35
there's always something to do there
30:39
Rome
30:41
yeah awesome
30:43
what is currently on your playlist
30:47
what is currently on my playlist
30:49
oh yeah
30:51
what's currently on my playlist is uh
30:55
my son has a has makes some playlists
30:57
he's a he does some DJing
30:59
so whatever he puts on the playlist that I can get into
31:02
that's it and then I love uh
31:04
Black Coffee up there we go again
31:06
same answer for two questions
31:08
so uh
31:08
Black Coffee is a DJ and his music is phenomenal
31:14
and you can you can listen to it at work
31:18
uh so it
31:20
it has an energy it has an energy fantastic
31:24
I will look that up okay
31:25
next question what is your favorite movie or TV show
31:31
uh
31:32
well I think what's happened with streaming
31:34
has taken away TV shows so you don't get many
31:38
you get like
31:39
a short that's not a TV show
31:41
uh what's my favorite movie
31:44
oh I love movies
31:45
I can't say a favorite I would say if someone told
31:49
asked me
31:50
what do you watch or what would you like to watch
31:54
I'll watch um
31:58
Glenn Gary Glenn Ross
32:02
check that out
32:03
it's great OK
32:06
will do
32:07
uh Pacino was nominated for a supporting actor
32:09
it's got Jack Lemmon it's got um
32:13
Pacino Jack
32:14
Alec Baldwin is in there for 10 minutes
32:16
it's like the defining thing of his career
32:18
um Ed Harris is in there
32:21
I believe and there is one
32:24
one more Kevin Spacey is in it
32:27
and it's amazing movie and then I like 7 7
32:31
so it's old enough that most people haven't seen it
32:35
it's very well written it's dark
32:37
um
32:39
and then everyone and then old
32:41
old movies
32:43
um not that they're my favorite
32:45
but they're like gems if someone tells me about a movie
32:48
that I haven't watched
32:50
uh
32:51
it could be 40 years old I'll watch it
32:53
but right now if you ask me
32:59
uh a movie to watch I would say
33:04
oh
33:06
Moscow on the Hudson
33:07
we were talking about that yesterday
33:09
Robin Williams movie
33:11
so you could do a great Robin Williams Marathon
33:14
um whether you watch that or um
33:20
good lord what's that movie he was in
33:24
Good Will Hunting so he does great in that
33:27
and then Awakenings 3 Robin Williams uh
33:30
I love
33:32
uh
33:35
Scorcese stuff but I would say the Boston movies
33:38
so Goodwill Hunting
33:41
uh The Departed
33:42
and The Town so I
33:43
that's another great movie
33:44
The Town is a great movie
33:45
so those are the things I like to watch
33:47
okay well I
33:48
I have a lot of movies to watch
33:49
so I appreciate the recommendations
33:51
here we go okay
33:52
are you more of a planner or more go with the flow
33:59
I'm more of a Tasmanian devil planner
34:03
which means I I have things planned to do
34:05
but the day is not
34:08
does not have that much time to give
34:12
I understand that
34:14
what is a small thing that makes your day better
34:21
uh small thing
34:23
my spouse
34:25
oh great answer
34:27
she's great she's great
34:29
um I wish for everyone to find someone who is
34:33
as much of an advocate and a supporter and um
34:38
you know a partner uh
34:42
I in order to do what we do in oncology
34:46
you need to be able to go into a private life
34:52
that is not fraught with stress
34:56
or you can handle the stress
34:59
and then you need someone who shares your psychosis
35:03
that's it you need to have that
35:07
that shared psychosis together
35:08
so that's helpful I've
35:11
I've never heard it put like that
35:12
but I kind of love it we need to put that on a sign
35:16
it is it's a DSMV4 diagnosis
35:20
it's called Folie à deux it's a shared psychosis
35:23
usually there's one person who has that psychosis
35:27
and then the other person just by being exposed to you
35:32
shares it
35:35
amazing all right
35:37
do you have a favorite quote
35:38
or a mantra that you live by
35:41
no I mean
35:42
I had I like quotes and I
35:45
and I and
35:46
and I love that but I don't have a favorite quote
35:48
and I don't have a mantra um
35:52
I just think
35:55
I I don't know how that's taken in in
35:58
in polite society to say
36:02
we have enough to do uh
36:05
so I I get
36:08
I mean I no
36:10
I don't have a favorite quote or a mantra
36:12
okay what advice would you give your younger self
36:17
I I
36:20
so I'm gonna
36:22
I'm gonna steal something that came from
36:24
I think an athlete said it just recently
36:27
I don't think I would interfere with my younger self
36:30
I like my pathway you know
36:33
someone would say like oh uh
36:35
invest in Apple like
36:37
good lord or
36:39
you know
36:40
enjoy life more I don't know
36:43
I love
36:45
I'm very respectful of the obstacles that came in
36:49
my path and the work needed to
36:51
to do to overcome them
36:54
and that journey has been rather rewarding
37:00
so I don't I don't say that to anyone who comes into
37:03
wants to come into medicine
37:04
the advice is you know
37:08
enjoy the enjoy the journey
37:12
perfect do you have a hidden talent
37:16
hidden to us
37:19
that will remain hidden to you
37:21
haha OK
37:22
I will I will respect that
37:24
alright A Cure In Sight
37:26
we don't go into that on the first date
37:28
haha
37:29
OK maybe next time
37:31
alright
37:32
OK um
37:33
I just have a couple more
37:34
what is something
37:35
that we would be surprised to learn about you
37:38
I don't know I'm a triplet
37:39
I have a brother and a sister
37:41
same age that's amazing
37:44
that is that is a surprising fact
37:46
I like that
37:47
if you could instantly master a new skill
37:49
what would it be
37:51
oh my god it would
37:52
the new skill would be to play the piano
37:56
that's a great one yeah
37:57
I had to say I wanted to say golf
38:00
but you know that's
38:02
that's dependent playing the piano
38:05
I I regret not spending more time on that
38:08
when I was a kid but it is
38:11
it has a it's mentally challenging
38:14
you can do it through your a
38:16
you know into your nineties
38:20
and it's wonderful
38:23
okay this is the last question
38:24
it's a two part question sweet or salty
38:27
and what is your favorite snack or treat
38:30
salty
38:31
um
38:33
my favorite snack or treat
38:35
I like a nice Cheetos with a Diet Coke
38:40
love that I also am guilty of loving a Diet Coke
38:45
so I relate
38:47
alright well
38:47
that concludes our episode
38:49
thank you so much for being here
38:50
we truly appreciate I appreciate the opportunity
38:53
and I really want to thank you for all the great work
38:56
you and your institution do
38:58
um anything that brings patients
39:02
into a better sense of understanding
39:06
better sense of comfort
39:08
and it leads to advocacy is just
39:13
it's not gold it's like plutonium
39:16
it is the most important
39:19
and valuable thing for patient care
39:22
well thank you for saying that
39:23
we appreciate it
39:24
we're happy to be here and do this work
39:25
if you all have any questions
39:27
that you would like us to pass along
39:28
please leave them in the comments
39:30
please like and subscribe
39:31
please let us know who you'd like to see featured next
39:34
and go to our website ACureInSight.org
39:37
we have lots of resources
39:38
the clinical trial list the physician finder
39:41
all kinds of great stuff and until next week
39:44
I hope you all stay well and have a wonderful week
39:47
so bye from us bye bye